Fuji Pharma Co., Ltd. (FRA:FUP)

Market Cap	271.28M +24.0%
Revenue (ttm)	323.66M +20.4%
Net Income	16.10M -2.5%
EPS	0.64 -5.1%
Shares Out	n/a
PE Ratio	16.85
Forward PE	n/a
Dividend	0.27 (2.65%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	10.20
Previous Close	10.30
Day's Range	10.20 - 10.20
52-Week Range	8.55 - 13.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 1,760
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FUP

Financial Performance

In fiscal year 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 14, 2026

Data Sources Report a data error